What You Should Know:
– Cognizant and Yseop, a leading AI software company, have joined forces to accelerate and streamline scientific content creation in the biopharmaceutical industry.
– The strategic partnership leverages Yseop Copilot, a generative AI tool, to transform medical writing, enhance productivity, and expedite the delivery of life-saving treatments.
Challenges of Traditional Medical Writing
The current process for creating scientific content is a significant bottleneck in drug development. Medical writers face a multitude of hurdles:
- High Costs and Time Consumption: Authoring, reviewing, and regulatory submissions are expensive and time-consuming endeavors.
- Multiple Standards and Templates: Adapting to various therapeutic areas and adhering to diverse regulatory standards creates complexity.
- Data Analysis and Writing Versatility: Analyzing vast amounts of clinical data within tight deadlines demands strong analytical skills.
- Tailored Communication: Writers must adjust their style to resonate with different audiences, from regulators to consumers.
Yseop Copilot: An AI-powered Assistant for Medical Writers
Yseop Copilot empowers scientific authors by acting as an intelligent assistant. It streamlines document creation, facilitates the verbalization of clinical data, and generates high-quality draft content. Here’s how it helps:
- Effortless Document Setup: Manage complex reports with ease.
- Data-Driven Writing: Transform data into clear and concise content.
- Improved Efficiency: Automate repetitive tasks and free up time for higher-value activities.
- Enhanced Regulatory Accuracy: Ensure compliance with regulations throughout the writing process.
- Faster Document Delivery: Reduce turnaround times for scientific content.
Cognizant: Accelerating Yseop’s Adoption in Biopharma
Cognizant plays a crucial role in driving the adoption of Yseop Copilot across the biopharma industry. Their contributions include:
- Collaboration with Yseop: Teamwork with Yseop’s customer success teams fosters a collaborative environment.
- Yseop AI Center of Excellence: A dedicated center will explore innovative Copilot use cases and provide system integration and managed services for joint clients.
“The expected partnership of Yseop’s capabilities to automate content generation for medical writing together with Cognizant’s Industry Solutions Group’s domain knowledge across the biopharmaceutical development chain will help our joint clients unlock new productivity, accelerate their speed-to-market and cut out a competitive advantage for themselves,” says Archana Ramanakumar, Senior Vice President and Global Head of Cognizant’s Industry Solutions Group.
